Ishita Roy

An Existing Drug Can Replace Steroids To Help Asthma And COPD Patients, Reveals Lancet Study

This medicine can treat asthma without steroids

"During a flare-up, it’s almost impossible to explain how you feel—you can barely breathe,” said 77-year-old Pointing from Banbury, England, in a recent news release.

For people like Pointing, a new clinical trial offers hope. Benralizumab, an existing injectable drug, may significantly reduce the severity of <a href="https://www.healthandme.com/health/asthma">asthma</a> and COPD attacks and could make it far less daunting, report researchers. The study is published in The Lancet Respiratory Medicine. While the drug has already been approved for treating asthma patients, it could also replace steroid medication as the go-to treatment for flare-ups.

As per the findings in the study, the monoclonal antibody outperformed steroids in reducing symptoms like coughing, wheezing, breathlessness, and phlegm production.

Trial results also showed that after three months, individuals taking benralizumab were four times less likely to experience an asthma or COPD attack compared to those on the steroid prednisolone.

The lead researcher Dr Mona Bafadhel, who is also the chair of respiratory Medicine at King's College London said, "This could be transformative for people with asthma and COPD. Treatment for these exacerbations hasn’t evolved in 50 years, despite causing 3.8 million deaths globally each year. Benralizumab, a safe and effective drug already used for severe asthma, showed greater effectiveness when given at the point of an exacerbation compared to steroid tablets, which are currently the only option available."

Pointing who was one of the participant of the trial, praised the drug and said that it was "fantastic" and that he did not experience the usual side effects he gets with the steroid tablets. "“Steroids used to ruin my sleep, especially the first night. But with benralizumab, I slept well and could go about my life without issues.”

It targets eosinophils, a type of white blood cell that drives lung inflammation during flare-ups. Eosinophilic exacerbations account for about 30% of COPD attacks and nearly half of asthma attacks. These episodes also involve a surge in eosinophiles in the lungs, and cause severe wheezing, coughing, and chest tightness.

The trial placed patients into three groups: one received benralizumab during flare-ups, another was given prednisolone tablets, and a third received both. The benralizumab group not only had fewer symptoms, but it also took longer to develop a serious episode that necessitated medical attention or hospitalization.

The researchers also discovered that the injections increased the individuals' overall quality of life.

Although the medicine is now provided by healthcare professionals, researchers anticipate it will be safe to administer at home or in a doctor's office in the future.

“Our study demonstrates enormous potential for asthma and COPD treatment,” said Dr. Sanjay Ramakrishnan, clinical senior lecturer at the University of Western Australia and one of the researchers. “COPD is the third leading cause of death worldwide, yet treatment remains outdated. We need life-saving options to prevent these patients from running out of time.”

With 3.8 million deaths annually attributed to asthma and COPD, researchers hope benralizumab can soon provide a modern, effective solution for managing these life-threatening conditions.

Health Conditions A-Z

health

asthma

asthma treatment

COPD

COPD attacks

lancet study for asthma

lancet study

Hidden Toxins at Home: Everyday Products That May Be Linked to Cancer

Do We Really Need To Eat More Than 3 Meals A Day?

ASMR Can Be Soothing, But Should Kids Watch Them?

Health News

10 Ways You Can Maximize Your Gym Exercises

10 Exercises You Can Do While Walking

10 Healthy Savoury Pancakes To Have For Breakfast

10 Herbal Tea Mixes For Winters

10 Habits To Ensure Your Teeth Health

10 Detox Juices You Should Try

10 Low Impact Exercises For Weight Loss

10 Foods That Should Be Part Of A Runners Diet

10 Gym Exercises Basketball Players Should Do

10 Light Foods You Can Eat Before Exercises

10 Ways To Beat The Sleep Spell In Office

10 Tips To Help Muscle Recovery

6-6-6 Walking Routine Can Help You Stay Fit

10 Breathing Exercises To Try When You’re Feeling Anxious

10 Ways To Beat Morning Fatigue

10 Type Of Squats You Can Do For Weight Loss

Soaked vs. Roasted Chickpeas: Which One is Healthier?

10 Ways For Busy People To Stay Active

10 High-Calorie Foods to Watch Out For At Gatherings

10 Brain Exercises to Improve Your Focus and Memory

Creative Ways to Complete Your 10,000 Steps Indoors

10 Best Carb Choices for Managing Type 2 Diabetes

10 White Foods to Avoid for Better Weight Loss Results

10 Delicious Mediterranean Diet Dinners: Low-Carb and High-Protein Options

Healthy and Protein-Packed Late-Night Snacks to Satisfy Your Cravings

10 Negative Habits That Drain Your Mind’s Power

10 Brain-Boosting Activities to Sharpen Your Mind

10 Protein-Rich Breakfast Dishes To Try

10 Signs Your Heart Is Healthy

10 Foods To Improve Your Brain Health

10 Foods That Boost Your Metabolism

10 Exercise To Improve Grip Strength

10 Staple Foods To Make Eating Healthy Easier

10 Foods You Should Eat If You Are Weight-Training

10 Basics Rules Of Weight Training

10 Ways To Deal With Winter Dry Skin

Workout Week: 10 Back Exercises To Do At Gym

10 Healthy Chicken Recipes For Winter

10 Morning Habits That Can Make You Sick

10 Superfood To Help You Build Immunity

"During a flare-up, it’s almost impossible to explain how you feel—you can barely breathe,” said 77-year-old Pointing from Banbury, England, in a recent news release.For people like Pointing, a new clinical trial offers hope. Benralizumab, an existing injectable drug, may significantly reduce the severity of asthma and COPD attacks and could make it far less daunting, report researchers. The study is published in The Lancet Respiratory Medicine. While the drug has already been approved for treating asthma patients, it could also replace steroid medication as the go-to treatment for flare-ups.What did The Study find?As per the findings in the study, the monoclonal antibody outperformed steroids in reducing symptoms like coughing, wheezing, breathlessness, and phlegm production.Trial results also showed that after three months, individuals taking benralizumab were four times less likely to experience an asthma or COPD attack compared to those on the steroid prednisolone.The lead researcher Dr Mona Bafadhel, who is also the chair of respiratory Medicine at King's College London said, "This could be transformative for people with asthma and COPD. Treatment for these exacerbations hasn’t evolved in 50 years, despite causing 3.8 million deaths globally each year. Benralizumab, a safe and effective drug already used for severe asthma, showed greater effectiveness when given at the point of an exacerbation compared to steroid tablets, which are currently the only option available."Pointing who was one of the participant of the trial, praised the drug and said that it was "fantastic" and that he did not experience the usual side effects he gets with the steroid tablets. "“Steroids used to ruin my sleep, especially the first night. But with benralizumab, I slept well and could go about my life without issues.”How does Benralizumab work?It targets eosinophils, a type of white blood cell that drives lung inflammation during flare-ups. Eosinophilic exacerbations account for about 30% of COPD attacks and nearly half of asthma attacks. These episodes also involve a surge in eosinophiles in the lungs, and cause severe wheezing, coughing, and chest tightness.The trial placed patients into three groups: one received benralizumab during flare-ups, another was given prednisolone tablets, and a third received both. The benralizumab group not only had fewer symptoms, but it also took longer to develop a serious episode that necessitated medical attention or hospitalization.The researchers also discovered that the injections increased the individuals' overall quality of life.Although the medicine is now provided by healthcare professionals, researchers anticipate it will be safe to administer at home or in a doctor's office in the future.“Our study demonstrates enormous potential for asthma and COPD treatment,” said Dr. Sanjay Ramakrishnan, clinical senior lecturer at the University of Western Australia and one of the researchers. “COPD is the third leading cause of death worldwide, yet treatment remains outdated. We need life-saving options to prevent these patients from running out of time.”With 3.8 million deaths annually attributed to asthma and COPD, researchers hope benralizumab can soon provide a modern, effective solution for managing these life-threatening conditions.